Q&A: Pharmacist Highlights Challenges in Vaccine Information Navigation Amid Changing Recommendations
Drug Topics
JULY 2, 2025
Drug Topics: What will be the likely impacts of this change that pharmacists will need to communicate with their patients?
Gaps Remain in MOUD Access Across Opioid Treatment Programs
Drug Topics
JUNE 30, 2025
March 18, 2025. Accessed June 30, 2025. Importance of Communication in Buprenorphine Initiation | APhA 2025. March 25, 2025. Accessed June 30, 2025. Drug Topics. Nowosielski B. Drug Topics.
Compounding 
504
504 Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Pneumococcal Vaccine Patient Education: What Pharmacists Should Know and Share
Drug Topics
JULY 14, 2025
Panelists discuss how pharmacists should educate patients about pneumococcal vaccines by providing current vaccine information statements (VIS) updated May 29, 2025, explaining common adverse effects like injection site reactions and mild systemic symptoms as normal immune responses, conducting thorough pre-vaccination screening for moderate-to-severe (..)
Vaccines 247
247 
Q&A: Expert Highlights Importance of Trusted Sources for Vaccine Information
Drug Topics
JULY 6, 2025
Further, she underscored the need for continued patient education, transparent communication, and a commitment to evidence-based medical guidance in an increasingly complex health care environment. Health care professionals emphasize patient education and reliable information in the evolving vaccine recommendation landscape.
Vaccines 381
381 
Independent Pharmacists’ Unique Role During Disaster Management Efforts
Drug Topics
JUNE 11, 2025
One of the most recent natural disasters was the late-2024 and early-2025 Los Angeles wildfires. Aside from properly preparing medications during a disaster, Phillips mentioned the importance of establishing communication with patients. April 8, 2025. Accessed April 8, 2025. January 9, 2025. Accessed April 8, 2025.
Q&A: Pharmacists Play Essential Role in Insulin Therapy Success
Drug Topics
JULY 15, 2025
Pharmacists play a vital role in helping patients understand and manage insulin therapy through clear communication, relatable analogies, and personalized education tailored to individual regimens and lifestyles.
FDA Approves Widaplik for Treatment of Hypertension
Drug Topics
JUNE 9, 2025
June 9, 2025. Accessed June 9, 2025. Recent Videos Related Content Statins Have No Additional Antidepressive Effects as Add-On Treatment Ashley Gallagher June 5th 2025 Article Investigators found that simvastatin added to escitalopram for patients with obesity and major depressive disorder did not have increased antidepressive effects.
FDA 282
282 
ACIP Panel Removal Sparks Concerns, Pharmacists Warn of More Vaccine Distrust
Drug Topics
JUNE 20, 2025
They stress that rebuilding trust is challenging and requires careful, empathetic communication. Pneumococcal Burden Remains Despite Immunization Expansion Ashley Gallagher June 9th 2025 Article The Advisory Committee on Immunization Practices voted to lower the pneumococcal recommendation to 50 years in October 2024.
Vaccines 316
316 
Gut Microbiome Composition Could Be Linked With Risk of Cognitive Impairment
Drug Topics
JUNE 18, 2025
Community pharmacies, which are very accessible to the public, are well positioned to address social determinants of health (SDOH), including food insecurity. In a session at the Pharmacy Quality Alliance Annual Meeting 2025, presenters stated that approximately 68% of patients have at least 1 unmet SDOH. June 18, 2025.
Communication 378
378 
Marketing in Pharma: Strategies that work in 2025
Pharma Marketing Network
APRIL 2, 2025
In 2025, the strategies that succeed are rooted in personalization, innovation, and real-time adaptability. In 2025, the ability to react to these preferences in near real time is what separates leading pharma marketing teams from the rest. FAQs What is the biggest trend in marketing in pharma in 2025?
FDA Softens August 2025 NDSRI Deadline—Progress Reports Now Accepted
The FDA Law Blog
JULY 8, 2025
On June 23, 2025, FDA updated its CDER Nitrosamine Impurity Acceptable Intake Limits webpage to permit manufacturers and sponsors more time to submit required changes for nitrosamine drug substance‑related impurities (NDSRIs) for approved or currently marketed products. By August 1, 2025: Complete confirmatory testing for at-risk products.
FDA 59
59 
10 Innovative Trends in Pharma Marketing: Strategies for Industry Success in 2025
Pharma Marketing Network
DECEMBER 4, 2024
As we approach 2025, emerging trends are reshaping how the industry engages with patients and healthcare providers. Companies are investing heavily in digital tools to streamline communication and build stronger connections. Patient-Centric Marketing Patients want to feel heard. Patient-Centric Marketing Patients want to feel heard.
What are the Top Pharma Podcasts in 2025?
Pharma Marketing Network
JUNE 14, 2025
But with hundreds of shows available, which ones stand out in 2025? In this article, we spotlight the most influential pharma podcasts of 2025 and explain why they’re worth tuning into. In 2025, pharma podcasts are no longer niche. Pharma podcasts have become a cornerstone of professional development in the life sciences.
The Healthcare Businesswomen’s Association (HBA) Announces its 2025 Rising Star and Luminary Honorees
Pharma Marketing Network
MARCH 27, 2025
The Healthcare Businesswomens Association (HBA) has proudly announced its 2025 class of Rising Star and Luminary honorees! Congratulations to the following honorees: 2025 HBA Rising Stars Jenn Wong Abbott Xongi Phaleng AbbVie Inc. We look forward to seeing you there! Vandana Rajakumar AbbVie Inc.
Strategies for digital success in hospital pharmacy
Hospital Pharmacy Europe
JULY 1, 2025
Microsoft Teams is a great example – during the pandemic, ‘Teams’ revolutionised communication across the NHS, but many staff didn’t receive formal training on using it effectively. Communication in a time of crisis is essential so take time to understand your audience and the channels they use.
Hospitals 84
84 
Why 2025 Will Be a Breakout Year for Pharma Marketing Innovation
Pharma Marketing Network
APRIL 28, 2025
Pharma marketing innovation is poised for an unprecedented surge in 2025, driven by new technologies, regulatory shifts, and evolving patient expectations. This article dives deep into why 2025 will mark a pivotal moment for pharma marketing and how savvy brands can stay ahead.
How to Choose the Right Pharma Marketing Vendor in 2025
Pharma Marketing Network
MAY 22, 2025
Selecting the right pharma marketing vendor in 2025 is no longer a simple matter of comparing capabilities or price points. This article breaks down a step-by-step framework for choosing the right pharma marketing vendor , highlighting key considerations, red flags, and best practices for collaboration in 2025.
Pharmaceutical Marketing in 2025: Trends, Tech, and Targeting That Matter Most
Pharma Marketing Network
MARCH 31, 2025
Introduction Pharmaceutical marketing is entering a new era in 2025, driven by rapid advancements in technology, evolving patient expectations, and tighter compliance demands. Similarly, patients benefit from communications that resonate with their condition, treatment stage, and lifestyle.
HIPAA 52
52 
Five for Friday June 6: Celebrating Success in Advancing Medication Use Quality
PQA
JUNE 6, 2025
Nearly 400 leaders from PQA member organizations attended the 2025 PQA Annual Meeting, May 19-21, to network, engage and gain actionable insights. By providing personalized resources, maintaining patient communication, and collaborating with health plans, pharmacists can play a crucial role in improving overall patient outcomes.
March 2025 Update: Get Ready for a Major Release of New and Improved eWizard Features!
Viseven
MARCH 11, 2025
Improve communication with your clients and achieve better customer engagement with our templates ! The post March 2025 Update: Get Ready for a Major Release of New and Improved eWizard Features! Contact our team today to set up a free consultation. appeared first on Viseven.
2024 IDstewardship Year End Review
IDStewardship
JANUARY 5, 2025
Article Posted January 2025 It was welcomed that 2024 did not feel like an extension of the 2020 COVID-19 pandemic as 2021-2023 had. As we look to 2025, this article provides a look back and checkpoint in the life of IDstewardship.com, LearnAntibiotics.com, and the IDstewardship social media profiles.In Natalie Boyer, Pharm.D.
Communication 130
130 Communication 130
130 
Changing the PAP Model
Pharmaceutical Commerce
JUNE 17, 2025
Given the strict state and federal regulations governing how manufacturers communicate with or support patients, companies face significant legal and regulatory risk when managing PAP programs.
HCP Targeting in Pharma Marketing
Pharma Marketing Network
JUNE 16, 2025
In this article, we’ll explore the most effective HCP targeting strategies shaping pharma marketing in 2025—from data segmentation and digital tools to content personalization and compliance. In 2025, HCP targeting helps brands focus their resources on high-value providers—those most likely to prescribe, influence peers, or educate patients.
HIPAA 52
52 
Déjà Vu: OPDP Again Targets Provider Branded Website of Accelerated Approval Drug in Second Untitled Letter of 2025
The FDA Law Blog
APRIL 13, 2025
By Sarah Wicks & Dara Katcher Levy FDAs Office of Prescription Drug Promotion (OPDP) issued its second Untitled Letter of 2025 to Taiho Oncology (Taiho) for a healthcare provider branded website for its drug LYTGOBI (futibatinib).
FDA 52
52 
Conference Coverage Recap: American Pharmacists Association Annual Meeting and Exposition 2025
Drug Topics
JUNE 23, 2025
Experts Debate Diabetes Care in Community Pharmacy vs Health Systems Despite evidence of improved diabetes outcomes, all pharmacy settings are capable of having a significant impact on diabetes care, according to a presentation at the American Pharmacists Association (APhA) 2025 Annual Meeting and Exposition.
How AI and machine learning are transforming drug discovery
Pharmaceutical Technology
JUNE 26, 2025
Fi Forrest June 26, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Credit: Shutterstock AI is revolutionizing drug discovery with its ability to analyze vast datasets. i] GlobalData: Tech Sentiment Polls Q1 2025, April 2025. link] [viii] GlobalData: February 20, 2025 Analyst Briefing. Front Genet.
Compounding 86
86 
UK enacts law to decentralise manufacture of personalised treatments
Pharmaceutical Technology
JULY 23, 2025
Abigail Beaney July 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The new legislation will reduce the time it takes for patients to receive these therapies from months to days. We may still continue to send you service-related and other non-promotional communications. Sign up for our daily news round-up!
Top 10 RPM Vendors 2025: Driving Results in Remote Patient Monitoring
PharmD Live
JUNE 23, 2025
This 2025 vendor landscape review highlights how PharmD Live stands out by combining pharmacist-led clinical expertise, AI-powered insights, and fully CMS-aligned virtual care services, delivering tangible, reportable results across complex patient populations. PharmD Live is uniquely positioned in 2025 to meet these needs.
HIPAA 52
52 
FDA Approves GSK’s Shingles Vaccine in Prefilled Syringe
Drug Topics
JULY 18, 2025
July 17, 2025. Accessed July 18, 2025. Accessed July 18, 2025. Accessed July 18, 2025. Accessed July 18, 2025. The FDA has approved a prefilled syringe format of the recombinant zoster vaccine Shingrix for the prevention of shingles, GSK said in a release. News Release. October 23, 2017. News Release.
Vaccines 343
343 
How to Improve your Pharma Network
Pharma Marketing Network
APRIL 25, 2025
As pharmaceutical brands face an unprecedented wave of digital transformation, strategic innovation, and shifting regulatory landscapes in 2025, optimizing your network has never been more critical. To build one that withstands the 2025 shifts, consider the following strategies.
HIPAA 52
52 
Pharmaceutical Advertising Trends To Watch
Pharma Marketing Network
JUNE 16, 2025
As we move deeper into 2025, brands are navigating a rapidly transforming landscape. These communications take into account a provider’s specialty, prescribing patterns, and even digital behavior. Pharmaceutical advertising has always been complex. Personalization is at the core of this evolution.
The future of clinical pharmacy in Europe with ESCP president Monika Lutters
Hospital Pharmacy Europe
MARCH 18, 2025
Worryingly, the advent of better information and communications technologies solutions in recent years is not helping matters. Shaping the future of clinical pharmacy through ESCP As ESCP president, Dr Lutters has several priorities for 2025. This is a huge problem.
Hospitals 52
52 
What is the Pharma Marketing Network?
Pharma Marketing Network
JUNE 15, 2025
Whether you’re a seasoned brand manager or a medical affairs communicator, chances are you’ve encountered the Network’s industry-shaping thought leadership or practical tools. Let’s explore what it is, what it offers, and why it matters more than ever in 2025.
A decade of driving medicines optimisation innovation in clinical pharmacy
Hospital Pharmacy Europe
APRIL 24, 2025
iMPROVE Launched on 1 March 2025, MOICs latest project is Innovation in person-centred Medication Prescribing and Review for Optimal Value and Efficacy (iMPROVE). Hope and priorities for medicines optimisation in 2025 As we progress through 2025, MOIC aims to build upon its achievements and enhance its influence.
Email Marketing Campaigns: A Valuable Tactic in Pharma Marketing
Pharma Marketing Network
APRIL 21, 2025
But are these campaigns truly worth the investment in 2025’s competitive and compliance-heavy landscape? With increasing pressure from regulatory bodies and rising media costs, pharma marketers are rediscovering the power of personalized communication. However, in 2025, the digital transformation continues to accelerate.
HIPAA 52
52 
BASF Opens GMP Manufacturing Facility in Michigan
PharmTech
JUNE 19, 2025
Communication between the manufacturing plant and retail stores. Image Credit: © Cagkan - © Cagkan - stock.adobe.com BASF announced on June 17, 2025 that it has opened a good manufacturing practice (GMP) facility in Wyandotte, Mich. June 17, 2025. Pharmaceutical Technology 2025 49 (4). Press Release. Haigney, S.
Dosage 59
59 
Late-Life Mood Disorders Could Be Associated With Alzheimer Disease, Dementias
Drug Topics
JUNE 11, 2025
June 9, 2025. Accessed June 10, 2025. Kreckel, RPh June 10th 2025 Article Our whole country needs to do better in providing harm reduction services, including naloxone and syringe service programs. REFERENCES 1. Mood disorders in late life may be early warning signs for dementia. News release. Alzheimers Dement. doi:10.1002/alz.70195
Recruiting and retaining pharmacists: developing an effective flexible working approach
Hospital Pharmacy Europe
JUNE 12, 2025
One respondent said flexible working reduced communication and another felt there was reduced resilience in the team. Reduced communication: Reduced communication can slow down interactions with multidisciplinary teams. Accessed June 2025]. Flexible and hybrid working practices in 2023: Employer and employee perspectives.
Hospitals 52
52 
FDA approves Sanofi and Regeneron’s Dupixent for bullous pemphigoid
Pharmaceutical Technology
JUNE 25, 2025
June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook BP is a chronic skin disease marked by severe itching, painful blisters, lesions and skin redness. In February 2025, the FDA accepted Dupixent’s supplemental biologics licence application (sBLA) for priority review. Credit: Toa55/Shutterstock.
FDA 52
52 
Vutrisiran marks first silencer approved for ATTR-CM
Pharmaceutical Technology
JUNE 12, 2025
GlobalData Healthcare June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook European KOLs with cardiomyopathy patients told GlobalData that they are waiting for vutrisiran’s launch for ATTR-wt. Give your business an edge with our leading industry insights. Login Registration is disabled.
Bharat Biotech acquires licence for GSK’s Shigella vaccine development
Pharmaceutical Technology
JUNE 13, 2025
June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. Give your business an edge with our leading industry insights. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
Vaccines 87
87 
Content Marketing Strategies Used in Pharma Marketing
Pharma Marketing Network
APRIL 16, 2025
In the ever-evolving healthcare landscape, especially in 2025, content marketing strategies have moved from optional to mission-critical for pharma brands. The most effective content marketing strategies in 2025 are omnichannel by design and adaptive in execution. But not just any content will do.
CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024
Pharmaceutical Technology
JUNE 19, 2025
GlobalData Healthcare June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The oligonucleotide market is well-positioned to drive the next wave of personalised treatment. billion from 2021 to 2025 year-to-date. Credit: Kateryna Kon via Shutterstock. ASOs accounted for more than half ($3.54
Q&A: How ACIP Changes Could Reshape Patient Care
Drug Topics
JULY 5, 2025
He emphasizes the critical need for health care providers, especially pharmacists, to independently evaluate scientific evidence, maintain open communication with patients, and proactively address vaccine-related concerns. Is this really, truly evidence-based, or is this ideology-driven recommendations?
Patient Care 247
247 
Let's personalize your content